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Abstract
Introduction: Normal and malignant breast tissue contains a rare population of multi-potent cells with the capacity to self-
renew, referred to as stem cells, or tumor initiating cells (TIC). These cells can be enriched by growth as ‘‘mammospheres’’ in
three-dimensional cultures.
Objective: We tested the hypothesis that human bone-marrow derived mesenchymal stem cells (MSC), which are known to
support tumor growth and metastasis, increase mammosphere formation.
Results: We foundthatMSCincreased human mammary epithelial cell (HMEC)mammosphere formationina dose-dependent
manner. A similar increase in sphere formation was seen in human inflammatory (SUM149) and non-inflammatory breast
cancer cell lines (MCF-7) but not in primary inflammatory breast cancer cells (MDA-IBC-3). We determined that increased
mammosphere formation can be mediated by secreted factors as MSC conditioned media from MSC spheroids significantly
increased HMEC, MCF-7 and SUM149 mammosphere formation by 6.4 to 21-fold. Mammospheres grown in MSC conditioned
media had lower levels of the cell adhesion protein, E-cadherin, and increased expression of N-cadherin in SUM149 and HMEC
cells,characteristic of a pro-invasive mesenchymalphenotype. Co-injectionwith MSCin vivo resulted ina reduced latency time
to developdetectableMCF-7 and MDA-IBC-3 tumors and increased the growth of MDA-IBC-3 tumors. Furthermore, E-cadherin
expression was decreased in MDA-IBC-3 xenografts with co-injection of MSC.
Conclusions: MSC increase the efficiency of primary mammosphere formation in normal and malignant breast cells and
decrease E-cadherin expression, a biologic event associated with breast cancer progression and resistance to therapy.
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Introduction
Tumors, like normal tissues, are composed of a heterogenous
population of cells with variable capacity for self-renewal.
Multipotent tumor cells with the capacity to self-renew and
recapitulate the tumors from which they were derived following
transplantation into immunocompromised mice are referred to as
tumor initiating cells (TIC) or cancer stem cells. TIC can be
characterized by specific cell surface marker expression patterns,
such as lin
2/CD44
+/CD24
2 or ALDH1 expression [1,2]. Breast
TIC can also be enriched by growth as spheres in anchorage-
independent, growth factor enriched, serum-free conditions,
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12180referred to as mammospheres [3,4]. Mammospheres formed from
normal human mammary epithelial cells have a higher number of
mammary stem cells, which can a form a functional mouse
mammary gland de novo [5]. Similarly, tumors grown as mammo-
spheres (also known as tumorspheres) are enriched with stem cells
markers, lin
2/CD44
+/CD24
2 and ALDH1, and have increased
capacity for tumor initiation in xenograft models [6].
We hypothesized that TIC may respond to microenviromental
signals which effect signaling and promote their survival. TIC
would then resemble normal tissue stem cells in this regard which
are dependent on their microenvironment or niche for mainte-
nance of survival factors and suppression of proliferation signals
[7]. One candidate cell type within the tumor microenvironment
to interact with TIC is the mesenchymal stem cell (MSC). MSC,
which are found in the bone-marrow and other tissues, exhibit a
marked tropism for tumors and increase tumor metastasis [8,9].
We analyzed the effect of MSC on mammosphere formation as
a surrogate marker for TIC and report that MSC increase primary
sphere formation from human mammary epithelial cells (HMEC)
and from E-cadherin expressing breast cancer cell lines, MCF-7,
SUM149, and a novel inflammatory line MDA-IBC-3. MSC
modulated cadherin expression in vitro and in vivo. This work
suggests that MSC secrete factors which promote mammosphere
formation which may represent a novel mechanism by which
MSC impact breast cancer progression.
Materials and Methods
Cell culture
MCF-7 breast cancer cells were obtained from American Type
Culture Collection (Manassas, VA, USA) and were cultured in
modified Eagle medium (MEM) supplemented with 10% heat-
inactivated fetal calf serum, 0.1 mM nonessential amino acids and
1 mM sodium pyruvate, 5 mg/ml insulin, 1 mg/ml hydrocortisone
and antibiotic-antimycotic. SUM149 cells were obtained from Dr
Stephen Ethier (Kramanos Institute, MI, USA) and are commer-
cially available (Asterand, Detroit, MI) and were cultured in
Ham’s F-12 media supplemented with 10% fetal bovine serum
(FBS), 1 mg/ml hydrocortisone, 5 mg/ml insulin and antibiotic-
antimycotic. HMEC were kindly provided by Dr Mani (MD
Anderson Cancer Center, Houston, USA) and were cultured in
MEGM:DMEM-F12 (1:1) supplemented with insulin, hEGF,
hydrocortisone and penstrep. CD16 cells, a differentiated
fibroblast cell line obtained from human embryonic lung, were
obtained from American Type Culture Collection (Manassas, VA,
USA). CD16 fibroblasts were cultured in MEM with Earl Salts
and L-glutamine with 10% FBS and antibiotic.
The MDA-IBC-3 cell line was generated from primary human
breast cancer cells isolated from pleural effusion fluid obtained on
a clinical protocol approved by the institutional review board from
a patient with inflammatory breast cancer (IBC). Between October
2006 and September 2009, 29 patients with metastatic breast
cancer and symptomatic pleural effusion at The University of
Texas M. D. Anderson Cancer Center underwent thoracentesis
and provided written informed consent for the use of residual
pleural fluid after pathologic assessment for research at The
University of Texas M. D. Anderson Cancer Center. The fluid
was specifically cultured in accordance with a separate protocol
detailing the use and de-identification of this material reviewed
and approved by the institutional review board (IRB). Tumor cells
were selected by serial transplant into the cleared mammary fat
pads of SCID/Beige immunocompromised mice and the resulting
tumor tissue passaged in monolayer and 3D culture for the
experiments described herein. Characterization and short tandem
repeat analysis are provided in the supplemental data (Supple-
mental Table S1). MDA-IBC-3 cells were cultured in Ham’s F12
with 10% FBS and 5 ml Insulin/L with 100 mg/L Hydrocortisone
and antibiotic.
Human MSC were isolated from the bone marrow of normal
individuals undergoing bone marrow harvest for allogeneic bone
marrow transplantation following informed consent, according to
institutional guidelines under the approved protocol, as described
previously [8]. Briefly, mononuclear cells were separated by
centrifugation over a Ficoll-Hypaque gradient (Sigma-Aldrich),
suspended in a-minimum essential medium (a-MEM) containing
20% FBS, L-glutamine and penicillin–streptomycin, and plated on
180 cm
2 dishes. After 3 days, non-adherent cells were removed by
washing with phosphate-buffered saline (PBS), and monolayers of
adherent cells were cultured until they reached confluence. Cells
were then trypsinized (0.25% trypsin with 0.1% EDTA) and
subcultured at densities of 5,000–6,000 cells/cm
2. Cell passages 3–
10 were used for the experiments. Characterization of MSC used
is provided in the supplemental data (Supplemental Figure S1).
Human omental derived adipose stromal cells were isolated from
human omentum under an IRB approved protocol according to
published protocols for adipose stromal cell isolation [10].
Omentum was derived from a patient with endometrial cancer
without omental metastasis.
Fluorescent marker labeling
Cell lines were labeled with the green fluorescent protein (GFP)
using a lentiviral vector, pFUGW [11] that was generously
provided by Dr. Baltimore (Caltech). The titers of virus stocks were
determined by calculating the percentage of GFP-positive (GFP
+)
293T cells transduced with serially diluted virus suspensions. For
transduction, the MCF-7 and MDA-IBC-3 cell lines were seeded
at moderate density overnight. Two hours before transduction, the
medium was changed, and then transductions were carried out for
24 h in the presence of 8 mg/mL polybrene (Sigma). The cells
were then FACS sorted and further expanded for injections. The
MSC were labeled similarly but with a red fluorescent protein
(RFP) generously obtained from Tsien’s lab (UCSD) that was
cloned into pFUGW construct in place of GFP.
Mammosphere assay
To generate mammospheres, cells were grown in serum-free,
growth factor enriched conditions in low attachment plates
[4,12,13]. Cells were grown in 6-well ultra-low attachment plates
in serum-free MEM supplemented with 20 ng/ml bFGF, 20 ng/
ml EGF and B27 (all from Invitrogen). Cells were plated at 20,000
cells/ml unless specified otherwise. Suspension cultures were
incubated for 1–10 days. Colonies were counted with an
automated colony counter (Oxford Optronix, Oxford, UK)
following MTT assay in order to increase the contrast and allow
automatic detection of spheres.
MSC conditioned media
MSCspheroidswere generated byplatingMSCat20,000cells/ml
in low attachment plates and cultured in mammosphere serum-free
growth factor enriched media in conditions identical to mammo-
sphere growth [4]. MSC spheroids were cultured for 5 days in
suspension cultures. Spheres were then removed by centrifugation
and supernatant was used as MSC conditioned media.
Western Blot
Mammospheres grown as described above were incubated for 5
days in 25% (volume) conditioned media derived from MSC
MSC Increase MS Formation
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buffer and western blots were performed according to standard
protocols. Briefly, aliquots of the supernatants containing 40 mg
protein were electrophoresed on 4–20% gradient sodium dodecyl
sulfate-polyacrylamide gels (Invitrogen) and transferred to poly-
vinylidene fluoride membranes (Bio-Rad Laboratories). The
membranes were incubated in 5% nonfat milk for 1 hour at
room temperature and then incubated at 4uC overnight with the
following antibodies: E-cadherin, N-cadherin, vimentin, fibronec-
tin (BD Biosciences), tenascin C (Santa Cruz), rhoC (Abcam) and
b-actin (Sigma). After incubation with the secondary antibody, the
membranes were washed and immunoreactivity was detected by
enhanced chemiluminescence. b-actin was used as a loading
control.
In vivo studies
Ten week old NOD/SCID gamma null mice (The Jackson
Laboratory, USA) were housed and used in accordance with
institutional guidelines of the University of Texas, M.D Anderson
Cancer Center under the Institutional Animal Care and Use
Committee (IACUC) approved protocols (ACUF 07-08-07213).
The UTMDACC’s animal care and use program has been fully
accredited by the Association for the Assessment and Accredita-
tion of Laboratory Animal Care International (AAALAC). GFP
+
MDA-IBC-3 and MCF-7 cells were injected with 0, 5 and 10%
MSC subcutaneously on both hindlimb of mice (5 mouse/group).
A total number of 1610
6 cells in 100 ml of PBS were administered
per injection site. Mice injected with MCF-7 tumors were
simultaneously implanted in the nape of the neck with 17b-
Estradiol pellets (0.36 mg/pellet, 60 days release (Innovative
Research). Tumor growth was monitored with caliper measure-
ments. When tumors were approximately 1.0 cm in size, mice
were euthanized and tumors were excised. A portion of tumor was
formalin fixed, paraffin-embedded, sectioned, and stained with
immunohistochemistry to detect E-cadherin. An additional
portion of tumors were mechanically disrupted, digested with
collagenase (12.5 mg/ml, 2 hours) and filtered through a 40 mm
filter (BD Biosciences). Tumor derived cells were then subjected to
cell sorting using flow cytometry to isolate GFP
+ cells. GFP
+ cells
were then centrifuged and resuspended in PBS and used for
mammosphere formation and western blot analysis. Three
thousand GFP
+ tumor derived cells were plated into low
attachment 96 cell plates in mammosphere media [3]. The
number of mammospheres in each well was counted after 15 days
after seeding. Remaining GFP
+ xenograft derived cells were
pelleted and resuspended in lysis buffer for western blot analysis.
Results
MSC promote mammosphere formation in normal
mammary epithelial cells
Normal human mammary epithelial cells (HMEC) with or
without 2, 5 or 10% MSC labeled with red fluorescent protein
(RFP) were plated into low-density suspension cultures in serum-
free growth factor supplemented media into ultra-low attachment
plates. Twenty-thousand cells were plated per well, including
MSC. MSC were found to interact as spheres and as single cells
with HMEC as soon as one day after plating (Figure 1A). After 5
to 10 days, MSC identified as RFP positive (RFP
+) cells were
associated with HMEC mammospheres and remained as part of
spheres for up to 15 days (Figure 1B). HMEC cells plated with
MSC demonstrated a dose-dependent increase in mammosphere
formation, with a nearly two-fold increase in sphere formation in
the presence of 10% MSC (Figure 1B, p,0.01).
MSC promote mammosphere formation in human breast
cancer cell lines
Next, we investigated whether direct exposure to MSC would
influence mammosphere formation of tumorigenic breast cell
lines. MCF-7 cells (labeled with green fluorescent protein, GFP
+)
were plated with or without increasing percentages of MSC (RFP
+
cells) at low-density into low-attachment plates with growth factor
supplemented serum-free media. MCF-7 is an estrogen receptor-
positive breast cancer, while SUM149 and MDA-IBC-3 are both
derived from a hormone receptor-negative inflammatory breast
cancer cells. Her2-neu is overexpressed in MDA-IBC-3 cells. The
presence of 2% MSC cells markedly increased the number of
SUM149 mammospheres formed (60 vs. 270, p,0.01) (Figure 2A).
MCF-7 mammospheres similarly increased markedly on exposure
to MSC (77 vs. 884, p,0.01 at 10 days after plating) (Figure 2B).
No statistically significant difference was observed between 2%,
5% and 10% MSC. The presence of MSC did not significantly
Figure 1. MSC increase mammosphere formation in normal mammary epithelial cells. HMEC and RFP
+ MSC were co-plated in low-density
suspension cultures. MSC associated with developing HMEC spheres on days 1–5 after plating (A). The number of mammospheres formed increased
with increasing number of MSC plated (* No MSC vs. 10% MSC, p,0.001) (B).
doi:10.1371/journal.pone.0012180.g001
MSC Increase MS Formation
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MSC containing mammospheres were spherical and well
organized in comparison to spheres formed from MCF-7 cells
alone at this time point (Figure 2F). Sphere formation was readily
assessable within several days.
MSC grew readily as spheres in mammosphere culture
(Figure 2D), but incorporate into spheres from tumor cells as
single cells (Figure 2E). Mammosphere size was significantly
increased (108 vs. 189 mm in spheres composed of MCF-7 cells
alone as compared to spheres plated with 20% MSC, p=0.003) a
finding not accounted for simply by increased incorporation of
MSC into the spheres, Figure 2E and 2F. The total number of cells
plated was held constant in each experiment such that fewer tumor
cells were plated in the combined cultures.
To determine if this quality is unique to MSC, we compared
mammosphere in the presence of 5% CD16 fibroblasts, which are
derived from human embryonic lung, and adipose stromal cells
derived from human omentum (OSC). Mammosphere formation
was increased in the presence of MSC and OSC and not
significantly in the presence of differentiated fibroblasts
(Figure 2G).
MSC-conditioned media increases mammosphere
formation
To determine if direct cell contact between MSC and tumor
cells was required, the impact of MSC conditioned media (MSC-
CM) on mammosphere formation was examined. MSC-CM was
generated by growing MSC as spheres using mammosphere
culture conditions for 5 days (Figure 2D). HMEC and MCF-7 cells
were cultured in serum-free mammosphere culture with an
increasing percentage of volume of serum-free MSC-CM. A
dose-dependent increase in mammosphere formation was seen in
HMEC, MCF-7, and SUM-149 cells. Fifty-percent MSC-CM
resulted in 9.6 and 21.0-fold increase in sphere formation after 5
days for HMEC and MCF-7 cells (Figure 3A, 3B and 3D). Ten
percent volume MSC-CM resulted in a 6.4-fold increase in
mammosphere formation of SUM149 cells one day after plating
(p,0.01) (Figure 3C). This early time point was used to minimize
any effect of sphere aggregation which increases over time even in
low density culture. However, MDA-IBC-3 cells did not form
more mammospheres when exposed to MSC-CM without MSC
(data not shown).
To determine if mammospheres formed from MSC-CM were
enriched with self-renewing cells, we passaged the spheres from
MCF-7 mammospheres. MCF-7 control cells and cells grown with
MSC-CM were replated as single cells. There was no difference in
serial passaging of MSC-CM derived spheres and untreated MCF-
7 mammospheres (data not shown).
MSC secreted factors result in altered metastasis-related
signaling molecules
Mammosphere formation in HMEC increases upon induction
of the epithelial to mesenchymal transition, which is associated
with cancer invasion and metastasis [14,15]. MSC have been
shown to interact with breast cancer cells in monolayer cell culture
promoting epithelial-mesenchymal transition (EMT) [16]. Fur-
thermore, MSC can increase breast cancer metastasis [15]. We
thus hypothesized that MSC may modulate EMT pathways,
resulting in increased mammosphere formation. To investigate
this, HMEC were plated in low-density cultures with and without
25% volume of MSC-CM. After 7 days, spheres were isolated and
expression of proteins involved in breast stem cell survival were
examined (Figure 3E). Cell lines that exhibit increased mammo-
sphere formation when cultured with MSC-CM all demonstrate
decreased E-cadherin expression. HMEC and SUM149 cells
exposed to MSC-CM additionally upregulated the pro-invasive N-
cadherin protein. Snail and Slug were also found upregulated after
incubation of SUM149 with MSC-CM (Supplemental Figure S2).
Next, we investigated the impact of MSC-CM on expression of
other mesenchymal proteins. RhoC activity has been shown to
reduce EMT-induced migration and also to regulate E-cadherin
expression [17] and is specifically implicated in IBC tumor
progression [18]. Increased rhoC was observed in HMEC and
SUM149 cells exposed to MSC-CM. While decreased E-cadherin
was apparent in the luminal cell line MCF-7, N-cadherin and
fibronectin are not expressed at baseline or after treatment with
MSC-CM and conversely, RhoC is down-regulated in this non-
IBC cell line.
MDA-IBC-3 cells which demonstrated no significant increase in
mammosphere formation had no detectable decrease in E-
cadherin or RhoC when cultured with MSC-CM. Fibronectin is
an extracellular matrix glycoproteins which binds integrins and
other cells extracellular matrix proteins which is involved in cell
migration and differentiation [19]. HMEC and SUM149 derived
mammospheres had higher levels of fibronectin in mammospheres
exposed to MSC-CM. No fibronectin was detected in MCF-7 or
MDA-IBC-3 mammospheres. Tenascin-C is expressed in the
stroma of tumors and is associated with a poor prognosis [20,21].
Tenascin-C binds to fibronectin and can reduce cell adhesion in
vitro [22]. We found that tenascin-C was increased in mammo-
spheres exposed to MSC-CM in HMEC and SUM149 cells.
Vimentin is an intermediated filament protein which is used as a
marker of the epithelial to mesenchymal transition [23]. We
detected vimentin only in SUM149 cells, where it was upregulated
in response to MSC-CM. Vimentin was detected in MSC after
extended exposure times (data not shown).
MSC promote growth of MDA-IBC-3 xenografts and
decrease E-cadherin expression in vivo
To determine if MSC impacted the TIC-enriched mammo-
sphere forming cells in vivo, MCF-7 and MDA-IBC-3 cells were
injected into NOD/SCID gamma null mice with and without
MSC. Consistent with previous reports [15,24], MCF-7 tumor
growth was not significantly increased by co-injection of MSC
(Figure 4A). However, MCF-7 tumors were detected earlier when
tumor cells were co-injected with MSC (average of 34 vs. 61 days
after injection with 10% MSC, p,0.001). MDA-IBC-3 tumors co-
injected with MSC were detected earlier and also grew more
rapidly (average of 20 vs. 32 days after injection with 10% MSC,
p,0.05 Figure 4A and 4B).
Figure 2. MSC increase mammosphere formation in breast cancer stem cells. Number of mammospheres formed/40,000 cells plated in low
density suspension cultures increased with an increasing percentage of MSC (*p,0.001 as compared to no MSC control) for breast cancer cell lines
SUM149 (A), MCF-7 (B) and MDA-IBC-3 (C). MSC formed spheroids under mammosphere culture conditions (D). Low-magnification image of MCF-7
(GFP
+) mammospheres demonstrating integrated red-fluorescent protein expressing MSC (E). MCF-7 mammospheres 5 and 10 days after plating with
and without co-plated MSC (0, 2, 5 and 10% MSC) (F). MCF-7 mammosphere formation is shown one day after plating with 10% stroma cells; MSC
(human bone marrow-derived MSC), Fb (human CD16 normal human lung fibroblasts) and OSC (human omental derived adipocyte stem cells) (G)
(*p,0.05 as compared to no MSC control).
doi:10.1371/journal.pone.0012180.g002
MSC Increase MS Formation
PLoS ONE | www.plosone.org 5 August 2010 | Volume 5 | Issue 8 | e12180To examine the in vivo effect of MSC on TIC surrogates, we
examined mammosphere formation and cell surface marker
expression from tumors injected with and without MSC. To
accomplish this, GFP expressing tumor cells were isolated from
both xenograft tumors injected with and without MSC (0, 5 and
10% MSC). Average percentage of GFP
+ cells isolated from
MDA-IBC-3 and MCF-7 tumors was 87% (standard deviation
9.5%) and 57% (standard deviation 25%) respectively. No
mammospheres were formed from GFP
+ MCF-7 tumor cells.
Mammosphere formation efficiency from GFP
+ MDA-IBC-3
xenograft cells was 3.3%, but was not significant different in
tumors with co-injected MSC (data not shown). Co-injection
with MSC did not increase the percentage of CD44
+CD24
2
MDA-IBC-3 cells. The percentage of GFP
+CD44
+CD24
2 cells
in xenografts generated with 0%, 5%, and 10% MSC was
1.75%, 1.02%, and 0.45% respectively (p=NS). Because MCF-
7 tumors were smaller and had fewer GFP
+ cells, there were
insufficient cells remaining after sorting for mammospheres to
assess GFP
+CD44
+CD24
2 cells in MCF-7 cells. In vitro MSC-
CM did not increase considerably the CD44
+CD24
2 population
on SUM149 cells (Supplemental Figure S3). Immunohisto-
chemical assessment of Ki-67 (2 tumors per group) demonstrates
staining in 60–95% of xenograft cells (from MCF-7 and MDA-
IBC-3 cells) with no significant difference or trend between
groups. To determine if MSC altered cadherin expression in
vivo,G F P
+ MDA-IBC-3 tumor cells were isolated from
xenografts with and without MSC were isolated and western
blots were performed (Figure 4C). E-cadherin expression was
decreased in MDA-IBC-3 tumor cells with co-injected MSC
(Figure 4C). RhoC expression in MDA-IBC-3 xenografts was
similar with and without co-injected MSC. MDA-IBC-3 did not
express detectable N-cadherin and fibronectin and vimentin.
Tenascin-C expression was lower in tumors with co-injected
MSC. Insufficient protein was available for western blot analysis
of E-cadherin in vivo from GFP
+ cells derived from MCF-7
tumors. Therefore, immunohistochemistry was performed on
MCF-7 xenografts as well as MDA-IBC-3 xenografts to detect
E-cadherin protein. Decreased E-cadherin expression was
appreciated in the presence of 5 and 10% MSC in MDA-
IBC-3 tumors, consistent with western blot analysis (Figure 4C
and D). In MCF-7 tumors, staining patterns were heteroge-
neous, with areas of lower E-cadherin expression were identified
in tumors containing MSC and were absent in tumors without
co-injected MSC (Figure 4D).
Figure 3. Impact of MSC conditioned media on mammosphere formation of normal human mammary epithelial cells and breast
cancer cells. Number of HMEC (A), MCF-7 (B) and SUM149 (C) spheres were counted one day after plating in the presence of an increasing
percentage of volume of MSC-CM. Images of 3D HMEC suspension cultures with and without MSC-CM (D) (*p,0.05 as compared to no MSC control).
Western blot analysis of HMEC, MCF-7, SUM149 and MDA-IBC-3 spheres samples cultured with or without MSC-CM (E).
doi:10.1371/journal.pone.0012180.g003
MSC Increase MS Formation
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The discovery that MSC demonstrate a unique tropism for the
tumor microenvironment has led to a great deal of interest in
understanding the function of MSC within tumors [9,25,26]. MSC
have been shown to increase the growth of certain cancers when
injected together with MSC and can increase the incidence of
breast xenograft metastasis [15]. However, a great deal remains
unknown about the interaction of MSC and breast cancers. In this
study, we report that MSC increase the capacity of normal
mammary epithelial cells and established breast cancer cell lines
(MCF-7 and SUM149) but not short-term primary breast cells
(MDA-IBC-3) to form primary mammospheres. Both direct
exposure to MSC, as well as MSC-conditioned media, promoted
mammosphere formation from HMEC, MCF7, and SUM149
demonstrating that MSC secrete a sphere-promoting factor to
which that these lines are sensitive. We hypothesize that this may
occur through an increase in EMT in breast cancer cells, since
Figure 4. MSC promote growth of xenografts and decrease E-cadherin expression in vivo. GFP
+ MDA-IBC-3 and MCF-7 cells were mixed
with MSC prior to injection into the hindimb of NOD-SCID mice. Tumor growth was measured with twice weekly caliper measurements to determine
the average days to develop detectable tumors (A) and tumor growth (B) (*p,0.05 as compared to no MSC control). Western blot analysis was
performed on GFP
+ MDA-IBC-3 cells from xenografts with and without co-injected MSC (C). Immunohistochemistry images of E-cadherin in tumor
sections from MDA-IBC-3 and MCF-7 xenografts with and without co-injected MSC (D).
doi:10.1371/journal.pone.0012180.g004
MSC Increase MS Formation
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and malignant (SUM149) breast mammospheres. Decreased full-
length E-cadherin expression was observed in vivo or in vitro in all
lines examined. In cells that express N-cadherin at baseline, this
downregulation of E-cadherin was accompanied by an increase in
mesenchymal proteins including N-cadherin and fibronectin.
The mesenchymal phenotype has previously been reported to
increase primary mammosphere formation. Mani et. al. demon-
strated that expression of EMT regulating transcription factors,
snail and twist, increased mammosphere formation [14]. Further-
more, mammospheres from snail and twist over-expressing cells
contained a higher percentage of cells with stem cells markers
suggesting that EMT generates cells with stem cells properties
[14]. Our findings are consistent with previous studies in which
MSC have been shown to interact with breast cancer cells in
monolayer cell culture to promote epithelial-mesenchymal tran-
sition (EMT) [16].
We examined whether exposure to MSC-CM could be
enriching for the growth of cells with stem cell properties.
However, while primary sphere formation was reproducibly
increased in a dose dependent manner in established cell lines,
secondary sphere formation was not increased and neither sphere
formation nor CD44
+CD24
2 cells were increased in MDA-IBC-3
tumors cultured with MSC. This suggests that the expansion of
mammospheres may represent an amplification of non-self-
renewing progenitors involved in the observed tumor growth
promotion and increased invasion [15] rather than self-renewing
tumor stem cells. Rigorous in vivo serial passaging experiments will
be required to determine if MSC influence the cancer stem cell
population.
Dittmer et. al. recently reported that MSC can integrate into
formed breast cancer spheroids, altering E-cadherin expression
and increasing breast cancer cell invasion. In contrast to our work,
these authors observed that MSC containing aggregates were
more disorganized, while we have observed that spheroids with
MSC appear more spherical and well organized than non-MSC
containing spheres [27]. This difference may be explained by the
fact that Dittmer et. al. were examining the effects of MSC added
to aggregates of spontaneously floating cells in monolayer serum-
containing culture as compared to our study in which the effect of
MSC was evaluated in spheres grown from single cells plated at
clonal density in stem cell promoting serum-free media. The
process of MSC integration into established spheres may result in
disrupted morphology. This may imply a differential effect on TIC
secondary to less reliance on E-cadherin for adhesion in TIC.
Strikingly, while the down-regulation of E-cadherin was
observed in vitro or in vivo in all cells examined, there are distinct
differences across cell lines in expression of other pro-invasion and
mesenchymal proteins. E-cadherin was decreased in both the
estrogen receptor (ER) positive luminal E-cadherin positive cells
(MCF-7) and in the ER negative E-cadherin positive cells
(SUM149). E-cadherin is a cell adhesion protein which functions
as a tumor supressor gene with forced expression of E-cadherin
resulting in reduced tumor cell invasion [28]. High levels of E-
cadherin are associated with better clinical outcomes in patients
with non-IBC [29]. However, E-cadherin has been proposed to
have a unique role in IBC where E-cadherin expression is present
in both the primary and in the tumor emboli found in the
angiolymphatics in the breast [18], prompting the hypothesis that
E-cadherin expression is dynamic, and potentially only transiently
down-regulated during metastasis [30]. In the Mary-X IBC mouse
model, it has been shown that the aggregates of tumor in emboli
are facilitated by a functional E-cadherin/b-catenin axis [31] and
that knock-down inhibits aggregates, and that further these
aggregates metastasize as E-cadherin positive clusters through a
passive process rather than hemotogenous spread [31]. To that
end, dominant negative E-cadherin in SUM149 cells inhibits
invasion as expected in non-IBC tumors. Here, however, we
demonstrate for the first time that MSC can promote the growth
of an IBC cell line, MDA-IBC-3, and that E-cadherin is down-
regulated in the larger MSC co-injected MDA-IBC-3 xenograft.
Given that IBC clearly can develop metastatic disease via
hematogenous spread as well as potentially passive spread via
the angiolymphatic channels we propose that IBC cells are capable
of both E-cadherin positive non-hemotogenous spread as well as
more well-described E-cadherin negative promoting invasive
behavior. We can not determine from this model if E-cadherin
is re-expressed after metastases are established.
Our findings demonstrate that MSC provoke breast cancer cells
to form mammospheres and assume a more mesenchymal
phenotype and that MSC integrate into breast cancer mammo-
spheres and decrease E-cadherin expression in both ER positive
luminal E-cadherin positive cells and ER negative E-cadherin
positive IBC cells. This suggests that MSC may represent a novel
therapeutic target either independently or by inhibiting the effects
of MSC on cadherin expression in breast cancer cells.
Supporting Information
Table S1 STR data from xenografts and in vitro culture of MDA-
IBC-3 cell line.
Found at: doi:10.1371/journal.pone.0012180.s001 (0.02 MB
PDF)
Figure S1 MSC express characteristic cell surface markers and
demonstrate multi-lineage potential. Cell surface marker expres-
sion was characterized with flow cytometry (A). MSC were
subjected to differentiation assays with and stained with Alizarin
Red S to detect osteoblast differentiation, Oil Red O to detect
adipocyte differentiation and Alcian Blue to detect chondrocyte
differentiation.
Found at: doi:10.1371/journal.pone.0012180.s002 (2.05 MB
TIF)
Figure S2 Western blot analysis of SUM149, MDA-IBC-3,
MCF-7, and HMEC spheres samples cultured with or without
MSC-CM.
Found at: doi:10.1371/journal.pone.0012180.s003 (0.57 MB TIF)
Figure S3 Flow cytometry analysis of expression of CD24 and
CD44 on SUM149 cells cultured as spheres with and without
MSC-CM.
Found at: doi:10.1371/journal.pone.0012180.s004 (2.26 MB TIF)
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